Showing results (451-460 of 472) with videos related to
Sort By:
Pageof 48
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2026
TROP2-targeted NIR-II fluorescence imaging for visualizing surgical margins and metastatic sentinel lymph nodes in breast cancersKang-Liang Lou, Jing-Wen Bai, Hong-Tan Liu, et al.Signal Transduction and Targeted Therapy|March 28, 2025
CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infectionXiaoming Liang, Yanan Zhou, Yun Yang, et al.Signal Transduction and Targeted Therapy|February 26, 2022
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concernTianhong Xie, Shuaiyao Lu, Zhanlong He, et al.Medcomm|August 5, 2025
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in ChinaYanan Zhou, Junbin Wang, Ranran Cao, et al.Signal Transduction and Targeted Therapy|November 5, 2024
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2Ran An, Hao Yang, Cong Tang, et al.Cell|May 5, 2022
Systematic discovery of mutation-directed neo-protein-protein interactions in cancerXiulei Mo, Qiankun Niu, Andrey A Ivanov, et al.Science (New York, N.Y.)|January 7, 2017
Regeneration of fat cells from myofibroblasts during wound healingMaksim V Plikus, Christian F Guerrero-Juarez, Mayumi Ito, et al.Nature Communications|December 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trialsJingyun Yang, Weiqi Hong, Huashan Shi, et al.Cell|April 23, 2022
Circular RNA vaccines against SARS-CoV-2 and emerging variantsLiang Qu, Zongyi Yi, Yong Shen, et al.Cell|May 14, 2022
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2Kun Xu, Ping Gao, Sheng Liu, et al.Pageof 48